Regen BioPharma (RGBP) Resumes Rally After Intermediate Correction  

After a lot of ups and downs over the past couple of weeks, Regen BioPharma Inc (OTC: RGBP) stock is back in action on Wednesday. At the time of writing, RGBP stock is trading higher by 32% at $0.025.

This morning, the company filed an 8-K stating that it sold 10,000 common shares of Oncology Pharma, Inc. to an unaffiliated third party for cash consideration of $250,000.

The stock had an amazing run-up from April 7th to 12th, when the stock soared 3100% from $0.0021 to as high as $0.0674. However, after the huge rally, the stock pulled back on profit booking and fell to as low as $0.0165 in today’s trading session – that’s a 75% correction from the peak. The stock got a lot of attention after it announced that it signed a licensing deal in relation to its pancreatic cancer treatment. Keep an eye on RGBP as the stock may continue to be volatile in coming sessions.

Michael Rowels

Weekend Contributor.Writing for business and finance publishers has become his passion over the last decades after he completed a master's degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/zjrlrgmy/public_html/wp-includes/functions.php on line 5107